doi:10.16150/j.1671-2870.2020.05.001

Abstract

CLC Number:

R544.1

References 29

[1]	Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice[J]. J Am Coll Cardiol, 2017, 69(14):1811-1820. doi: S0735-1097(17)30569-7 pmid: 28385310
[2]	中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9):727-736.
[3]	Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China[J]. J Hypertens, 2013, 31(7):1465-1471. doi: 10.1097/HJH.0b013e328360ddf6 URL
[4]	Xu Z, Yang J, Hu J, et al. Primary aldosteronism in patients in China with recently detected hypertension[J]. J Am Coll Cardiol, 2020, 75(16):1913-1922.
[5]	Hu Y, Zhang J, Liu W, et al. Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension[J]. J Clin Endocrinol Metab, 2020, 105(4):dgz293.
[6]	Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients[J]. Arch Intern Med, 1981, 141(12):1589-1593. pmid: 7030245
[7]	Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916. doi: 10.1210/jc.2015-4061 pmid: 26934393
[8]	Burrello J, Monticone S, Buffolo F, et al. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism[J]. J Hypertens, 2016, 34(5):920-977. doi: 10.1097/HJH.0000000000000880 pmid: 27031933
[9]	Glinicki P, Jeske W, Bednarek-Papierska L, et al. The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration(ADRR)[J]. J Renin Angiotensin Aldosterone Syst, 2015, 16(4):1298-1305. doi: 10.1177/1470320313519487 URL
[10]	Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives[J]. J Intern Med, 2019, 285(2):126-148. doi: 10.1111/joim.12831 pmid: 30255616
[11]	宋颖, 何文雯, 杨淑敏, 等. 化学发光法测定血浆醛固酮浓度/肾素浓度比值筛查原发性醛固酮增多症的[J]. 中华内科杂志, 2016, 55(1):6-10.
[12]	Li Y, Liu Y, Li J, et al. Sodium infusion test for diagnosis of primary aldosteronism in chinese population[J]. J Clin Endocrinol Metab, 2016, 101(1):89-95. doi: 10.1210/jc.2015-2840 URL
[13]	Wang K, Hu J, Yang J, et al. Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism[J]. J Clin Endocrinol Metab, 2020, 105(7):dgaa282.
[14]	Song Y, Yang S, He W, et al. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study[J]. Hypertension, 2018, 71(1):118-124. doi: 10.1161/HYPERTENSIONAHA.117.10197 URL
[15]	陈适, 曾正陪, 宋爱羚, 等. 卡托普利试验在原发性醛固酮增多症诊断中的应用[J]. 中华内科杂志, 2017, 56(6):402-408.
[16]	Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[J]. Hypertension, 2014, 63(1):151-160. doi: 10.1161/HYPERTENSIONAHA.113.02097 URL
[17]	Ma D, Liu X, Zeng L, et al. The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism[J]. J Hypertens. 2020-08-29 [2020/ 10/ 16]. https://pubmed.ncbi.nlm.nih.gov/32868641/.
[18]	Jiang Y, Zhang C, Wang W, et al. Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism[J]. J Clin Endocrinol Metab, 2015, 100(5):1837-1844. doi: 10.1210/jc.2014-3551 URL
[19]	Küpers EM, Amar L, Raynaud A, et al. A clinical prediction score to diagnose unilateral primary aldosteronism[J]. J Clin Endocrinol Metab, 2012, 97(10):3530-3537. doi: 10.1210/jc.2012-1917 URL
[20]	Zhang Y, Niu W, Zheng F, et al. Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score[J]. J Hypertens, 2017, 35(12):2486-2492. doi: 10.1097/HJH.0000000000001488 pmid: 28708774
[21]	Xiao L, Jiang Y, Zhang C, et al. A novel clinical nomogram to predict bilateral hyperaldosteronism in Chinese patients with primary aldosteronism[J]. Clin Endocrinol (Oxf), 2019, 90(6):781-788. doi: 10.1111/cen.13962 URL
[22]	蒋怡然, 张翠, 姜蕾, 等. 螺内酯单药治疗及低剂量螺内酯联合治疗特发性醛固酮增多症的有效性及安全性[J]. 中华内分泌代谢杂志, 2018, 34(6):479-484.
[23]	Karagiannis A, Tziomalos K, Papageorgiou A, et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism[J]. Expert Opin Pharmacother, 2008, 9(4):509-515. doi: 10.1517/14656566.9.4.509 pmid: 18312153
[24]	Amar L, Azizi M, Menard J, et al. Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism[J]. Hypertension, 2010, 56(5):831-838. doi: 10.1161/HYPERTENSIONAHA.110.157271 URL
[25]	Bogman K, Schwab D, Delporte ML, et al. Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase(CYP11B2)[J]. Hypertension, 2017, 69(1):189-196. doi: 10.1161/HYPERTENSIONAHA.116.07716 URL
[26]	Zheng FF, Zhu LM, Nie AF, et al. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma[J]. Hypertension, 2015, 65(3):622-628. doi: 10.1161/HYPERTENSIONAHA.114.03346 URL
[27]	Li X, Wang B, Tang L, et al. GSTA1 expression is correlated with aldosterone level in KCNJ5-mutated adrenal aldosterone-producing adenoma[J]. J Clin Endocrinol Metab, 2018, 103(3):813-823. doi: 10.1210/jc.2017-00950 URL
[28]	Cao Y, Zhou W, Li L, et al. Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types[J]. Cell Res, 2018, 28(5):601-604. doi: 10.1038/s41422-018-0019-5 URL
[29]	Omata K, Satoh F, Morimoto R, et al. Cellular and gene-tic causes of idiopathic hyperaldosteronism[J]. Hypertension, 2018, 72(4):874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086 pmid: 30354720

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 29

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 460-468.
[2]	CHENG Yibang, LI Mingxuan, CHEN Bo, CAO Sheng, JIANG Gonghao, XU Jianzhong, LI Yan, WANG Jiguang. Diagnostic value of measuring the plasma renin and aldosterone by chemiluminescence immunoassay in the primary aldosteronism [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 474-480.
[3]	LI Zhoutong, ZHANG Wei, WANG Jiguang. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 487-493.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 525-527.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 528-530.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 450-453.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 454-459.
[8]	HUANG Yongyan, YANG Lina, CAO Jiumei, WANG Wei. Cloud-based solution assisted blood pressure management in outpatient setting [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 319-324.
[9]	WANG Yajuan, GUO Qianhui, ZHANG Dongyan, CHENG Yibang, CHEN Ling, ZHU Dingliang, LI Yan. Prevalence of overweight and obesity and analysis of blood pressure related factors among children and adolescents in Xinzhuang community, Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 575-580.
[10]	HUANG Jianfeng, SHENG Changsheng, HUANG Qifang, CHENG Yibang, GUO Qianhui, ZHANG Dongyan, WANG Jiguang, LI Yan. Study on circadian blood pressure rhythmandrelated influencing factors in outpatients [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 313-318.
[11]	WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60.
[12]	GUO Tongshuai, CHU Chao, WANG Yang, REN Keyu, MU Jianjun. Effects of salt loading and potassium supplement on circadian blood pressure profile in salt-sensitive Chinese subjects [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 582-586.
[13]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 567-570.
[14]	CHEN Hui, GUO Qianhui, XU Jie, CHENG Yibang, ZHANG Dongyan, WANG Ying, HUANG Qifang, SHENG Changsheng, LI Yan. Prevalence and determinants of asymptomatic intracranial artery stenosis assessed by transcranial Doppler ultrosonography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 592-595.
[15]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 576-581.